Fuda Cancer Hospital
Fuda Cancer Hospital
China, Kanton
| China | Türkei | Österreich | |
| Strahlentherapie bei Sarkomen | von $10,500 | von $3,250 | von $18,000 |
| Strahlentherapie bei Darmkrebs | von $11,500 | von $7,000 | von $12,000 |
| Gamma-Messer | von $7,800 | von $6,300 | von $32,000 |
| Chemotherapie bei Brustkrebs | von $14,800 | von $1,200 | von $15,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Osteosarkom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Osteosarkom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Osteosarkom-Behandlungsreise nie allein.
Professor Shixin Liu, MD, PhD, ist Fachbereichsleiter des Onkologiezentrums. Zuvor war er Präsident des Krebskrankenhauses der Provinz Jilin und Direktor des Forschungsinstituts für Krebsprävention und -therapie. Er ist Professor der zweiten Ebene und Promotionsbetreuer. Er erhielt die Sonderzulage des Staatsrats, die 4. Auszeichnung 'National Famous Doctor (Outstanding Contribution)' sowie den Ehrentitel 'Vorbild ärztlicher Ethik'.
Er ist auf die umfassende Diagnostik und Behandlung bösartiger Tumoren spezialisiert, mit Schwerpunkt auf präziser Strahlentherapie thorakaler und abdomineller Tumoren. Er beherrscht IMRT, VMAT und SBRT bei Lungen-, Speiseröhren-, Brust- und Rektumkarzinomen.
Zu seinen Leitungsfunktionen zählen die stellvertretenden Vorsitzämter bei CMA Radiation Oncology, CACA Radiotherapy und CACA Particle Therapy. Er gehört dem Ständigen Ausschuss der CSCO an und ist stellvertretender Vorsitzender des CSCO-Expertenkomitees für Strahlenonkologie. Zudem ist er stellvertretender Vorsitzender der CPAM Radiation Oncology und Mitglied des Ständigen Ausschusses der CSMEA. Er ist Vorsitzender der Sektion Strahlenonkologie der Jilin Medical Association. Er gehört den Redaktionsbeiräten des Chinese Journal of Radiation Oncology und des Practical Journal of Cancer an.
China uses a multimodal protocol for osteosarcoma. This strategy combines neoadjuvant chemotherapy, surgical limb-salvage, and postoperative adjuvant chemotherapy. Doctors follow guidelines from the Chinese Society of Clinical Oncology. These protocols prioritize high-dose drug regimens and precision surgery to maximize survival. Successful treatment often involves intensive inpatient care.
Bookimed Expert Insight: Chinese oncology centers often favor a high-intensity inpatient chemotherapy model. Fuda Cancer Hospital stands out by offering over 10 types of minimally invasive therapies. This variety allows doctors to treat advanced cases where standard surgery might be difficult. Their focus on technology like NanoKnife provides options for late-stage patients from over 100 countries.
Patient Consensus: Patients note that treatment is strictly protocol-driven but emphasize seeking second opinions before surgery. They emphasize that access to the best outcomes often requires traveling to specialized high-volume cancer hospitals.
China provides advanced osteosarcoma therapies including targeted agents and cell-based immunotherapies. Specialized centers utilize multi-kinase inhibitors and cryosurgical ablation for metastatic cases. The country hosts 14% of global osteosarcoma clinical trials. Leading facilities integrate genomic profiling with precision oncology protocols for refractory bone tumors.
Bookimed Expert Insight: Clinical data from JCI-accredited facilities like Fuda Cancer Hospital indicates a shift toward multi-modal management. Their approach uses over 10 types of minimally invasive therapies to manage late-stage cancer. We observe that high-volume centers serving over 30,000 international patients often combine immunotherapy with vascular interventional therapy. This strategy aims to improve tumor response when traditional chemotherapy has reached its limits.
Patient Consensus: Patients emphasize that finding an experienced orthopedic oncology team is more important than the hospital's general reputation. Many recommend verifying if a facility performs complex limb-salvage surgery frequently before starting any advanced or alternative therapy plan.
China is home to top-rated oncology centers like Fuda Cancer Hospital and Xiamen Humanity Hospital. These facilities specialize in limb-salvage surgeries and advanced ablation. Many hold JCI accreditation and employ multidisciplinary teams. They treat complex sarcomas using precise radiotherapy and targeted protocols.
Bookimed Expert Insight: Patient volume is a major quality indicator in China. Fuda Cancer Hospital treats over 30,000 patients annually and maintains a 4.6-star rating. This high volume often correlates with better surgical outcomes in rare bone cancers. We recommend choosing centers with dedicated bone tumor departments rather than general clinics.
Patient Consensus: Patients emphasize finding surgeons who perform limb-sparing procedures weekly. They note that having pathology, imaging, and chemotherapy under one roof is essential for success.
Traditional Chinese Medicine (TCM) serves as a supportive adjuvant therapy alongside surgery and multi-agent chemotherapy in China. It optimizes outcomes by mitigating side effects and supporting the immune system. Integrated protocols often include acupuncture and herbal formulations to improve patient quality of life and tolerance for intense oncology regimens.
Bookimed Expert Insight: While major centers like Xiamen Humanity Hospital focus on high-precision radiotherapy, facilities like Fuda Cancer Hospital in Guangzhou demonstrate the regional trend of offering over 10 types of minimally invasive therapies to reduce reliance on aggressive systemic chemotherapy. This shift allows TCM to play a more proactive role in recovery since patients maintain higher baseline strength than those on standard high-dose protocols.
Patient Consensus: Patients note that TCM is most effective for regaining appetite and sleep during recovery. They emphasize that while herbal medicine provides holistic comfort, it must never delay surgery for this aggressive cancer.
International patients can access specialized oncology care in China effectively by utilizing JCI-accredited facilities and dedicated international medical wings. Modern centers provide rapid diagnostic turnaround and advanced therapies. Navigating the system requires pre-arranged medical visas, digital payment setup, and coordination via international patient departments.
Bookimed Expert Insight: Data from Fuda Cancer Hospital shows they have treated over 30,000 patients from 100 countries. This high international volume indicates that choosing major tertiary centers in cities like Guangzhou or Xiamen simplifies the paperwork process. These clinics are better equipped to handle foreign passports and provide the necessary official invitation letters for visa approval.
Patient Consensus: Patients note it is vital to bring all imaging and pathology records in digital form. Having a bilingual advocate or using a dedicated international desk makes navigating daily hospital tasks much smoother.